BRAF inhibitors and their immunological effects in malignant melanoma-论文-万方医学网

BRAF inhibitors and their immunological effects in malignant melanoma

导出原文传递

翻译打印收藏纠错

作者： Adams, Rebecca ^[1] ; Coumbe, Jack E. M. ^[2] ; Coumbe, Ben G. T. ^[3] ; Thomas, Jennifer ^[4] ; Willsmore, Zena ; Dimitrievska, Marija ; Yasuzawa-Parker, Monica ; Hoyle, Maximilian ; Ingar, Suhaylah ; Geh, Jenny L. C. ; MacKenzie Ross, Alastair D. ; Healy, Ciaran ; Papa, Sophie ; Lacy, Katie E. ; Karagiannis, Sophia N.

作者单位： St Johns Inst Dermatol,Kings Coll London ^[1] Royal Marsden Hosp ^[2] Kings & St Thomas Hosp,Guys & St Thomas NHS Fdn Trust ^[3] Dept Med Oncol,Guys & St Thomas NHS Fdn Trust ^[4]

关键词 BRAF combination therapy immune checkpoint inhibitors MAPK pathway melanoma treatment resistance tumor microenvironment PROTEIN-KINASE PATHWAY TUMOR MICROENVIRONMENT MEK INHIBITION ACQUIRED-RESISTANCE PLUS PEMBROLIZUMAB CUTANEOUS MELANOMA 1ST-LINE TREATMENT ANTITUMOR-ACTIVITY PATIENTS PTS RAF KINASE

发布时间 2022-10-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除